RetractedArticleBioMed research international2021

Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms.

Haifeng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.